2023 NCS CME Symposium - DOACs and Intracranial Hemorrhage: Best Practices to Optimize Outcomes

This CME Symposium takes place during the 2023 Neurocritical Care Society Annual Meeting #NCS2023 on Thursday, August 17, 2023 from 12:15 PM - 1:15 PM MST at the Phoenix Convention Center, Phoenix, Arizona.

HAZLET, N.J. - July 11, 2023 - PRLog -- In this CME Symposium, during the 2023 Neurocritical Care Society Annual Meeting #NCS2023, expert faculty will discuss how direct oral anticoagulants (DOACs) have become widely used for the prevention and treatment of venous thromboembolism, stroke prevention in atrial fibrillation, and management of patients with coronary artery disease or peripheral artery disease. Large clinical trials have demonstrated that DOACs are as effective and safer than warfarin and are  now widely recommended by guidelines. Despite their superior safety, a small percentage of patients suffer intracranial  hemorrhage, which is associated with 30-day mortality rates approaching 50%. Specific agents that reverse anticoagulation  with factor Xa inhibition and with oral direct thrombin inhibition have demonstrated effectiveness in clinical trials and are now  preferred therapies in guidelines and statements from the American Heart Association/American Stroke Association (endorsed  by multiple societies including the Neurocritical Care Society) and the American College of Cardiology Expert Consensus Decision Pathway. There is a lack of clinician awareness of prudent initial interventions for intracranial hemorrhage, clinical profiles of reversal agents, and guideline recommendations for reversal of anticoagulants.  Intracranial hemorrhage is a complex clinical event that has been shown to benefit from specially trained, multidisciplinary care; a multidisciplinary team is recommended in clinical practice guidelines to improve outcomes and reduce mortality. Therefore, in this program, Program Chair Dr. Joshua Goldstein and an expert multidisciplinary faculty (Dr. Casey May, Dr. Anne Alexandrov, and Dr. Ashkan Shoamanesh) will provide attendees with best practices for optimal management of intracranial hemorrhage.

Click here for more information

CHAIR

Joshua Goldstein, MD, PhD
Professor of Emergency Medicine
Harvard Medical School
Endowed Chair in Emergency Medicine Research
Massachusetts General Hospital
Boston, Massachusetts

FACULTY

Anne Alexandrov, PhD, AGACNP-BC, ANVP-BC,
NVRN-BC, ASC-BC
Professor of Nursing and Neurology
The University of Tennessee Health Science Center
Memphis, Tennessee

Casey May, PharmD, BCCCP
Clinical Associate Professor
The Ohio State University College of Pharmacy
Columbus, Ohio

Ashkan Shoamanesh, MD
Associate Professor of Medicine
Marta and Owen Boris Chair in Stroke Research and Care
McMaster University
Hamilton, Ontario, Canada

This educational activity is intended for clinicians managing patients experiencing intracranial hemorrhage.

Voxmedia LLC gratefully acknowledges the educational grant provided by AstraZeneca Pharmaceuticals.

Voxmedia LLC designates this live activity for a maximum of 1.0 AMA PRA Category Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Pre-registration is for planning purposes only and does not guarantee seating. For additional CME/CE activities visit www.CMEPlanet.com #NCS2023 #DOACs #VTE #anticoagulation #stroke

Contact
Voxmedia
***@voxmedia.us
Photos: (Click photo to enlarge)



Read Full Story - 2023 NCS CME Symposium - DOACs and Intracranial Hemorrhage: Best Practices to Optimize Outcomes | More news from this source

Press release distribution by PRLog